Clinical Trial: Impact of Pinaverium Bromide on Bile Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title:
Brief Summary: Pinaverium bromide can be used to treat symptoms related to irritable bowel syndrome (IBS) and functional disorders of the biliary tract. In this study, pinaverium bromide was compared with Vitamin C for the facilitation of bile duct cannulation in patients. The primary outcome was successful deep bile duct cannulation. The second outcome was the major papillary orifice, bile juice flow from the papilla, time to achieve deep bile duct cannulation, and fluoroscopy time for deep bile duct cannulation in the pinaverium bromide group versus Vitamin C group.
Detailed Summary:
Sponsor: Changhai Hospital
Current Primary Outcome: cannulation time for deep bile duct cannulation [ Time Frame: 2 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- bile juice flow from the major papilla [ Time Frame: 2 days ]
- appearance of the major papillary orifice [ Time Frame: 2 days ]
Original Secondary Outcome: Same as current
Information By: Changhai Hospital
Dates:
Date Received: July 22, 2016
Date Started: July 2016
Date Completion: October 2017
Last Updated: August 26, 2016
Last Verified: August 2016
